bcl-2 gene therapy exacerbates excitotoxicity

Human Gene Therapy

Volumn 10, Issue 10, 1999, Pages 1715-1720

  Simon, Perikles D ^a   Vorwerk, Christian K ^a   Mansukani, Sharad S ^a   Chen, Shu Jen ^b   Wilson, James M ^b   Zurakowski, David ^c   Bennett, Jean ^a   Dreyer, Evan B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; VIRUS VECTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; GENE THERAPY; GENETIC TRANSDUCTION; NERVE CELL; NONHUMAN; PROTO ONCOGENE; RAT; RETINA DISEASE;

ANIMALS; CELL SURVIVAL; DEPENDOVIRUS; EXCITATORY AMINO ACID AGONISTS; GANGLIA; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; N-METHYLASPARTATE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033166476     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017716     Document Type: Article

References (42)

1. ALLSOPP, T.E., WYATT, S., PATERSON, H.F., and DAVIES, A.M. (1993). The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73, 295-307.
2. ANTONSSON, B., CONTI, F., MOTESSUIT, S., LEWIS, S., MARTINOU, I., BERNASCONI, L., BERNARD, A., MERMOD, J.J., MAZEI, G., MAUNDRELL, K., GAMBALE, F., SADOUL, R., and MARTINOU, J.C. (1997). Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370-372.
3. BENNETT, J., TANABE, T., SUN, D., ZENG, Y., KJELDBYE, H., GOURAS, P., and MAGUIRE, A.M. (1996). Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nature Med. 2, 649-654.
4. BENNETT, J., DUAN, D., ENGELHARDT, J.F., and MAGUIRE, A.M. (1997). Real-time, noninvasive in vivo assessment of adenoassociated virus-mediated retinal transduction. Invest. Ophthalmol. Vis. Sci. 38, 2857-2863.
5. BENNETT, J., ZENG, Y., BAJWA, R., KLATT, L., LI, Y., and MAGUKE, A.M. (1999). Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse. Gene Ther. 5, 1156-1164.
6. BLACKLOW, N.R., HOGGAN, M.D., and KAPIKIAN, A.Z. (1968). Epidemiology of adeno-associated virus infection in a nursery population. Am. J. Epidemiol. 88, 368-378.
7. BONFANTI, L., STRETTOI, E., CHIERZI, S., CENNI, M.C., LIU, X.H., MARTINOU, J.C., MAFFEI, L., and RABACCHI, S.A. (1996). Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2. J. Neurosci. 16, 4186-4194.
8. BONFOCO, E., KRANIC, D., ANKARCRONA, M., NICOTERA, P., and LIPTON, S.A. (1995). Apoptosis and necrosis: Two distinct events induced respectively by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U.S.A. 92, 7162-7166.
9. CAYOUETTE, M., and GRAVEL, C. (1997). Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. Hum. Gene Ther. 8, 423-430.
10. CHAO, D.T., and KORSMEYER, S.J. (1998). BCL-2 family: Regulators of cell death. Annu. Rev. Immunol. 16, 395-419.
11. CHEN, J., FLANNERY, J.G., LAVAIL, M.M., STEINBERG, R.H., XU, J., and SIMON, M.I. (1996). bcl-2 overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc. Natl. Acad. Sci. U.S.A. 93, 7042-7047.
12. CORY, S. (1995). Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13, 513-543.
13. CORY, S., STRASSER, A., JACKS, T., CORCORAN, L.M., METZ, T., HARRIS, A.W., and ADAMS, J.M. (1994). Enhanced cell survival and tumorigenesis. Cold Spring Harbor Symp. Quant. Biol. 59, 365-375.
14. DUAN, D., FISHER, K.J., BURDA, J.F., and ENGELHARDT, J.F. (1997). Structural and functional heterogeneity of integrated recombinant AAV genomes. Virus Res. 48, 41-56.
15. GAO, G.P., QU, G., FAUST, L.Z., ENGDAHL, R.K., XIAO, W., HUGHES, J.V., ZOLTICK, P.W., and WILSON, J.M. (1998). High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. Hum. Gene Ther. 9, 2353-2362.
16. GARCIA VALENZUELA, E., GORCZYCA, W., DARZYNKIEWICZ, Z., and SHARMA, S.C. (1994). Apoptosis in adult retinal ganglion cells after axotomy. J. Neurobiol. 25, 431-438.
17. HALBERT, C.L., STANDAERT, T.A., AITKEN, M.L., ALEXANDER, I.E., RUSSELL, D.W., and MILLER, A.D. (1997). Transduction by adeno-associated virus vectors in the rabbit airway: Efficiency, persistence, and readministration. J. Virol. 71, 5932-5941.
18. HERMENS, W.T., and VERHAAGEN, J. (1998). Viral vectors, tools for gene transfer in the nervous system. Prog. Neurobiol. 55, 399-432.
19. JOSEPH, R.M., and LI, T. (1996). Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 37, 2434-2446.
20. KAPLITT, M.G., and MAKIMURA, H. (1997). Defective viral vectors as agents for gene transfer in the nervous system. J. Neurosci. Methods 71, 125-132.
21. KLÖCKER, N., CELLERINO, A., and BÄHR, M. (1998). Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells in vivo. J. Neurosci. 18, 1038-1046.
22. KRAJEWSKI, S., TANAKA, S., TAKAYAMA, S., SCHIBLER, M.J., FENTON, W., and REED, J.C. (1993). Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53, 4701-4714.
23. LEWIN, A.S., DRENSER, K.A., HAUSWIRTH, W.W., NISHIKAWA, S., YASUMURA. D., FLANNERY, J.G., and LAVAIL, M.M. (1998). Ribozyme resuce of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nature Med. 4, 967-971.
24. LIPTON, S. (1993). Prospects for clinically tolerated NMDA antagonists. Trends Neurosci. 16, 527-532.
25. LUCAS, D.R., and NEWHOUSE, J.P. (1957). The toxic effect of sodium L-glutamate on the inner layers of the retina. Am. Med. Assoc. Arch. Ophthalmol. 58, 193-201.
26. MINN, A.J., VELEZ, P., SCHENDEL, S.L., LIANG, H., MUCHMORE, S.W., FESIK, S.W., FILL, M., and THOMPSON, C.B. (1997). Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature (London) 385, 353-357.
27. OFFEN, D., BEART, P.M., CHEUNG, N.S., PASCOE, C.J., HOCHMAN, A., GORODIN, S., MELAMED, E., BERNARD, R., and BERNARD, O. (1998). Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 95, 5789-5794.
28. OLNEY, J.W. (1969). Glutamate-induced retinal degeneration in neonatal mice: Electron microscopy of the acutely evolving lesion. J. Neuropathol. Exp. Neurol. 28, 455-474.
29. OLTVAI, Z.N., MILLIMAN, C.L., and KORSMEYER, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
30. PERRY, V.H. (1981). Evidence for an amacrine cell system in the ganglion cell layer of the rat retina. Neuroscience 6, 931-944.
31. REED, J.C. (1997). Double identity for proteins of the Bcl-2 family. Nature (London) 387, 773-776.
32. SCHENDEL, S.L., ZHIHUA, X., MONTAL, M.O. MATSUYAMA, S., MONTAL, M., and REED, J.C. (1997). Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. U.S.A. 94, 5113-5118.
33. SCHLESINGER, P.H., GROSS, A., YIN, X.M., YAMAMOTO, K., SAITO, M., WAKSMAN, G., and KORSMEYER, S.J. (1997). Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. U.S.A. 94, 11357-11362.
34. SHAPIRO, S.S., and WILK, M.B. (1965). An analysis of variance test for normality (complete samples). Biometrika 52, 591-611.
35. SHIMIZU, S., EGUCHI, Y., KAMIIKE, W., FUNAHASHI, Y., MIGNON, A., LACRONIQUE, V., MATSUDA, H., and TSUJIMOTO, Y. (1998). Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Biochemistry 95, 1455-1459.
36. SNOECK, H.W., TAO, W., and KLOTMAN, M.E. (1997). Adeno-associated viral vectors: Background and technical aspects. Exp. Nephrol. 5, 514-520.
37. SOKAL, R.R., and ROHLF, F.J. (1995). Biometry. (W.H. Freeman, New York) pp. 272-292.
38. STRASSER, A., HUANG, D.C., and VAUX, D.L. (1997). The role of teh bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochim. Biophys. Acta 1333, F151-F178.
39. TSANG, S.H., CHEN, J., KJELDBYE, H., LI, W.S., SIMON, M.I., GOURAS, P., and GOFF, S.P. (1997). Retarding photoreceptor degeneration in Pdegtm1/Pdegtm1 mice by an apoptosis suppressor gene. Invest. Ophthalmol. Vis. Sci. 38, 943-950.
40. VANDERHEIDEN, M.G., CHANDEL, N.S., WILLIAMSON, E.K., SCHUMACKER, P.T., and THOMPSON, C.B. (1997). Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627-637.
41. VORWERK, C.K., LIPTON, S.A., ZURAKOWSKI, D., HYMAN, B.T., SABEL, B.A., and DREYER, E.B. (1996). Chronic low dose glutamate is toxic to retinal ganglion cells; toxicity blocked by memantine. Invests. Ophthalmol. Vis. Sci. 37, 1618-1624.
42. YANG, E., and KORSMEYER, S.J. (1996). Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88, 386-401.